Clinical Validation of a Continuous Monitoring Mobile Cardiac Detection Device for Atrial Fibrillation

Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide, with stroke being among the most prevalent and harmful outcomes.1 Because nearly 25% of patients with AF appear asymptomatic, questions regarding the screening of patients at risk for AF (e.g., based on CHA2DS2-VASc score) could help clinical decisions to prescribe prophylactic anticoagulation therapy for effective stroke prevention.2,3 Current evidence highlights new approaches of real-time continuous assessment of rhythmic states of AF, non-AF, and paroxysmal AF (PAF).

Source: The American Journal of Cardiology - December 9, 2022 Category: Cardiology Authors: Subhash Banerjee, Tony Das, Jerrold Grodin, Nicole Minniefield, Shirling Tsai, Rahul Banerjee, Ken Persen, Scott Novak Source Type: research